The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection ...

Newly FDA-approved HIV prevention drug, Yeztugo, offers protection for six months—yet the need for a vaccine remains, say ...

Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent ...

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...

Kennedy said that removing all 17 members of the CDC's vaccine advisory panel was "necessary to reestablish public confidence ...

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It’s the first step in an anticipated global rollout that could ...

It reduces transmissions by up to 96%, but now world governments and big-dollar funders will need to step in.

Dr. Fiona Havers, who studied medicine at the University of Washington, says the wholesale dismissal of the CDC's scientific ...

A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

A key vaccine advisory panel handpicked by Health and Human Services Secretary Robert F. Kennedy Jr. is set to vote on a vaccine ingredient wrongly linked to autism as part of its scaled-down ...